A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.
Burgoyne AM, Vann KR, Joshi S, Morales GA, Vega FM, Singh A, Pal D, Merati AB, Kutateladze TG, Durden DL.
Burgoyne AM, et al. Among authors: morales ga.
Cell Discov. 2020 Jul 28;6(1):49. doi: 10.1038/s41421-020-0181-z. eCollection 2020.
Cell Discov. 2020.
PMID: 32793389
Free PMC article.
No abstract available.